跳至主要内容
临床试验/EUCTR2009-011446-26-SE
EUCTR2009-011446-26-SE进行中(未招募)不适用

A randomized, placebo-controlled, double blind, parallel group phase II study of anti-ESBL IgY for the eradication of ESBL Klebsiella pneumoniae and Escherichia coli in faeces in carriers

ppsala University0 个研究点开始时间: 2011年5月2日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age = 18 years.
  • Positive faecal test for ESBL-gene and positive culture for ESBL Klebsiella pneumoniae and/or Escherichia coli in at least one of two samples taken during screening at the same occasion (duplicate sample).
  • Written Informed Consent.
  • Male and female
  • No antimicrobial therapy within 14 days prior to start of treatment
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

排除标准

  • Swallowing dysfunction
  • Egg allergy
  • Anticipated bad compliance
  • Participation in any other clinical trial

研究者

发起方
ppsala University

相似试验